Pimsa P. Progression Free Survival with Erlotinib in First Line Treatment EGFR Mutated Non-Small Cell Lung Cancer Stage IV in Sunpasitthiprasong Hospital. J Health Sci BCNSP [internet]. 2026 Apr. 27 [cited 2026 Sep. 17];10(1):e287170 . available from: https://he01.tci-thaijo.org/index.php/bcnsp/article/view/287170